نتائج البحث - "Martine, Bagot"

101

Mélanome acral chez un patient atteint de kératodermie palmoplantaire de type mal de Méléda : une association fortuite ?

المؤلفون: Martine Bagot, Emmanuelle Bourrat, G. Hickman, M. Korbi, Emilie Routier

المصدر: Annales de Dermatologie et de Vénéréologie. 146:730-736

مصطلحات موضوعية: 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, Dermatology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::7d2c07f0e90c9e1a2af40c1f69d0ea60Test
https://doi.org/10.1016/j.annder.2019.08.013Test

102

IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial

المؤلفون: Maarten H. Vermeer, Martine Bagot, Federico Rotolo, Cécile Bonnafous, Hélène Sicard, Anne Marie-Cardine, Hatem A. Azim, Caroline Ram-Wolff, Sean Whittaker, Maxime Battistella, Michael S. Khodadoust, Carine Paturel, Armand Bensussan, Pierluigi Porcu, Basem M. William, Youn H. Kim

المساهمون: Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Immunologie, dermatologie, oncologie, Oncodermatologie, immunologie et cellules souches cutanées (IDO (U976 / UMR_S 976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Diderot - Paris 7 (UPD7), Gvh et Gvl : Physiopathologie Chez l'Homme et Chez l'Animal, Incidence et Role Therapeutique, Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de Dermatologie [AP-HP Hôpital Saint-Louis], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Recherche & Développement, Innate Pharma

المصدر: Lancet Oncology
Lancet Oncology, Elsevier, 2019, 20 (8), pp.1160-1170. ⟨10.1016/S1470-2045(19)30320-1⟩

مصطلحات موضوعية: Male, 0301 basic medicine, medicine.medical_specialty, Skin Neoplasms, Maximum Tolerated Dose, [SDV]Life Sciences [q-bio], Population, Phases of clinical research, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gastroenterology, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, medicine, Clinical endpoint, Humans, education, ComputingMilieux_MISCELLANEOUS, Aged, education.field_of_study, Mycosis fungoides, Dose-Response Relationship, Drug, business.industry, Cutaneous T-cell lymphoma, Not Otherwise Specified, Receptors, KIR3DL2, Middle Aged, medicine.disease, Lymphoma, T-Cell, Cutaneous, 3. Good health, Lymphoma, Clinical trial, 030104 developmental biology, Oncology, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Female, Neoplasm Recurrence, Local, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28ce3c922b3a855c25f033db0b020d6bTest
https://doi.org/10.1016/s1470-2045Test(19)30320-1

103

ICOS is widely expressed in cutaneous T-cell lymphoma and its targeting promotes potent killing of malignant cells

المؤلفون: Jean-Jacques Grob, Rémy Castellano, Florent Amatore, N. Bonnet, Reda Bouabdallah, Amandine De Croos, Philippe Gaulard, Daniel Olive, Saskia Ingen-Housz-Oro, Martine Bagot, Emmanuel Delaporte, Florence Orlanducci, Nicolas Ortonne, Marc Lopez, Armelle Goubard, Armand Bensussan, Laurent Gorvel, Jean-Marc Schiano